(Q43887658)

27 November 2017

Expression of insulin-like growth factor 2 in mesenchymal neoplasms (English)

1 reference

27 November 2017

1 reference

Sonja E Steigen

1

1 reference

27 November 2017

David F Schaeffer

series ordinal

2

1 reference

27 November 2017

Robert B West

series ordinal

3

1 reference

27 November 2017

Torsten O Nielsen

series ordinal

4

1 reference

27 November 2017

1 May 2009

1 reference

27 November 2017

1 reference

27 November 2017

22

1 reference

27 November 2017

914-921

1 reference

27 November 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.48

27 November 2017

0 references

cites work

The insulin-like growth factor system and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Regulation of growth and metabolism by imprinted genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Insulin-like growth factors and their binding proteins: biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Insulin-like growth factor ligands, receptors, and binding proteins in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Computational model for the IGF-II/IGF2r complex that is predictive of mutational and surface plasmon resonance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Molecular characterisation of soft tissue tumours: a gene expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Classification and subtype prediction of adult soft tissue sarcoma by functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Gene expression profiling of human sarcomas: insights into sarcoma biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Tissue microarrays in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

The role of KIT in the management of patients with gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

The discovery of receptor tyrosine kinases: targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Doege-Potter syndrome: hypoglycemia associated with malignant solitary fibrous tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Solitary Fibrous Tumor of the Pleura with Associated Hypoglycemia: Doege-Potter Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

The biology behind mTOR inhibition in sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

Evidence that somatomedin is synthesized by multiple tissues in the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

The control of growth

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Nuclear beta-catenin in mesenchymal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Growth factor receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.48

7 January 2021

10.1038/MODPATHOL.2009.48

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference